Anodic voltammetric behavior and determination of cefixime in pharmaceutical dosage forms and biological fluids


Gölcü A., Dogan B., Ozkan S.

TALANTA, cilt.67, sa.4, ss.703-712, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67 Sayı: 4
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.talanta.2005.03.020
  • Dergi Adı: TALANTA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.703-712
  • Anahtar Kelimeler: cefixime, voltammetry, pharmaceuticals, serum samples, urine samples, breast milk samples, oxidation, SPECTROPHOTOMETRIC DETERMINATION, CEPHALOSPORINS, FORMULATIONS, CEFOTAXIME, OXIDATION, DRUG
  • İstanbul Teknik Üniversitesi Adresli: Hayır

Özet

The voltammetric behavior of cefixime was studied using cyclic, linear sweep, differential pulse and square wave voltammetric techniques. The oxidation of cefixime was irreversible and exhibited diffusion controlled process depending on pH. The oxidation mechanism was proposed and discussed. Different parameters were tested to optimize the conditions for the determination of cefixime. The dependence of current intensities and potentials on pH, concentration, scan rate, nature of the buffer was investigated. According to the linear relationship between the peak current and the concentration, differential pulse (DPV) and square wave (SWV) voltammetric methods for cefixime assay in pharmaceutical dosage forms and biological fluids were developed. For the determination of cefixime were proposed in acetate buffer at pH 4.5, which allows quantitation over the 6 x 10(-6) -2 x 10(-4) M range in supporting electrolyte and spiked serum sample; 8 x 10(-6) -2 x 10(-4) M range in urine sample; 6 x 10(-6)-1 x 10(-4) M range in breast milk samples for both techniques. The repeatability, reproducibility, precision and accuracy of the methods in all media were investigated. No electroactive interferences from the excipients and endogenous substances were found in the pharmaceutical dosage forms and in the biological samples, respectively. (c) 2005 Elsevier B.V. All rights reserved.